Results of a randomized, placebo-controlled, first-in-human trial of topical CY-002 in patients with cutaneous warts.
CHDR
Pagan L, Yfanti C, Rijneveld R, Todd M, Jongste P, Feijen JJ, Klaassen ES, Bouwes Bavinck JN, Struijk L, de Koning MNC, Prestegarden L, Niemeyer-van der Kolk T, van Poelgeest MIE, Rissmann R
